RA CAPITAL MANAGEMENT, L.P. - 31 Mar 2025 SCHEDULE 13G/A Report for Avalo Therapeutics, Inc. Common Stock, $0.001 par value per share (AVTX)

Filing Manager
RA CAPITAL MANAGEMENT, L.P.
Reporting Manager
RA Capital Management, L.P.
Security
Avalo Therapeutics, Inc. Common Stock, $0.001 par value per share
Symbol
AVTX
Shares outstanding
11,054,616 shares
Disclosed Ownership
1,094,407 shares
Ownership
9.9%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 16:49:49 UTC
Date of event
31 Mar 2025
Next filing
14 Nov 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
RA Capital Management, L.P. 9.9% 1,094,407 0 1,094,407 /s/ Peter Kolchinsky By Peter Kolchinsky, Authorized Signatory
Peter Kolchinsky 9.9% 1,094,407 0 1,094,407 /s/ Peter Kolchinsky Peter Kolchinsky
Rajeev Shah 9.9% 1,094,407 0 1,094,407 /s/ Rajeev Shah Rajeev Shah
RA Capital Healthcare Fund, L.P. 9.9% 1,094,407 0 1,094,407 /s/ Peter Kolchinsky By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager